Substance P enhances HIV-1 replication in latently infected human immune cells

被引:25
作者
Li, Y [1 ]
Douglas, SD [1 ]
Song, L [1 ]
Sun, S [1 ]
Ho, WZ [1 ]
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Immunol & Infect Dis, Philadelphia, PA 19104 USA
关键词
AIDS/HIV; neuroimmunology; cytokines; immunomodulators;
D O I
10.1016/S0165-5728(01)00439-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Substance P (SP) is a potent modulator of neuroimmunoregul at ion. SP receptors are present on human monocytes and T lymphocytes, and SP alters the function of these immune cells. We investigated the effects of SP on HIV-1 replication in latently infected human immune cells. SP significantly enhanced HIV-1 replication in the latently infected promonocytic cell tine (U1) and T lymphocyte line (ACH-2) stimulated with tumor necrosis factor (TNF-alpha). When added to these cells in combination with TNF-alpha, SP also enhanced HIV-1 gag gene expression in U1 and ACH-2 cells. This stimulatory effect of SP was associated with the activation of HIV-LTR (long terminal repeat) driven chloramphenicol acetyltransferase (CAT) gene expression, and could be blocked by pretreatment of U1 and ACH-2 cells with an SP receptor antagonist RP-67,580, indicating specific SP receptor-mediated regulation. Furthermore, the addition of SP to the cultures of latently infected peripheral blood mononuclear cells isolated from HIV-1-infected patients enhanced HIV-1 gag gene expression. Thus, SP may play a potentially important role as a positive regulator of HIV-1 replication in latently infected monocytes and lymphocytes. These observations may have significant implications toward understanding the role of neuropeptide SP in the immunopathogenesis of HIV-1 infection and AIDS. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 47 条
[1]   HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P [J].
Annunziata, P ;
Cioni, C ;
Toneatto, S ;
Paccagnini, E .
AIDS, 1998, 12 (18) :2377-2385
[2]  
Azzari C, 1992, Pediatr Med Chir, V14, P577
[4]  
BLACK PH, 1994, ANTIMICROB AGENTS CH, V38, P1
[5]   Neurogenic amplification of immune complex inflammation [J].
Bozic, CR ;
Lu, B ;
Hopken, UE ;
Gerard, C ;
Gerard, NP .
SCIENCE, 1996, 273 (5282) :1722-1725
[6]   DISTINCT MODES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL LATENCY REVEALED BY SUPERINFECTION OF NONPRODUCTIVELY INFECTED CELL-LINES WITH RECOMBINANT LUCIFERASE-ENCODING VIRUSES [J].
CHEN, BK ;
SAKSELA, K ;
ANDINO, R ;
BALTIMORE, D .
JOURNAL OF VIROLOGY, 1994, 68 (02) :654-660
[7]   IN-VIVO FATE OF HIV-1-INFECTED T-CELLS - QUANTITATIVE-ANALYSIS OF THE TRANSITION TO STABLE LATENCY [J].
CHUN, TW ;
FINZI, D ;
MARGOLICK, J ;
CHADWICK, K ;
SCHWARTZ, D ;
SILICIANO, RF .
NATURE MEDICINE, 1995, 1 (12) :1284-1290
[8]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[9]   Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines [J].
Chun, TW ;
Engel, D ;
Mizell, SB ;
Ehler, LA ;
Fauci, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) :83-91
[10]  
COVAS MJ, 1994, CLIN EXP IMMUNOL, V96, P384, DOI 10.1111/j.1365-2249.1994.tb06039.x